{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:06:25Z","timestamp":1759730785894,"version":"3.41.2"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100016956","name":"Melinta Therapeutics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016956","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>\n            Delafloxacin, a recently approved anionic fluoroquinolone, was tested within an international resistance surveillance program. The\n            <jats:italic>in vitro<\/jats:italic>\n            susceptibilities of 7,914 indicated pathogens causing acute bacterial skin and skin structure infections (ABSSSI) were determined using Clinical and Laboratory Standards Institute (CLSI) broth microdilution MIC testing methods.\n          <\/jats:p>","DOI":"10.1128\/jcm.00339-18","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T09:40:10Z","timestamp":1527673210000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Delafloxacin\n            <i>In Vitro<\/i>\n            Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone"],"prefix":"10.1128","volume":"56","author":[{"given":"M. A.","family":"Pfaller","sequence":"first","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Flamm","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. P.","family":"McCurdy","sequence":"additional","affiliation":[{"name":"Melinta Therapeutics, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Pillar","sequence":"additional","affiliation":[{"name":"Micromyx, LLC, Kalamazoo, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Shortridge","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Jones","sequence":"additional","affiliation":[{"name":"JMI Laboratories, North Liberty, Iowa, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.1005205"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/976273"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq302"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03154.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/313677"},{"key":"e_1_3_3_7_2","first-page":"355","volume-title":"Quinolone antimicrobial agents","author":"Low DE","year":"2003","unstructured":"Low DE. 2003. Quinolone resistance and its clinical relevance, p 355\u2013386. In Hooper DC, Rubenstein E (ed), Quinolone antimicrobial agents, 3rd ed. ASM Press, Washington, DC.","edition":"3"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/649554"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix603"},{"key":"e_1_3_3_10_2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","author":"Workowski KA","year":"2010","unstructured":"Workowski KA, Berman S, Centers for Disease Control and Prevention. 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 59(RR-12):1\u2013110.","journal-title":"MMWR Recomm Rep 59(RR-12)"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00772-17"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02609-16"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.935470"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.15.39"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.009"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx329"},{"key":"e_1_3_3_17_2","unstructured":"Baxdela\u2122. 2017. Baxdela package insert. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/208610s000 208611s000lbl.pdf. Accessed September 2017."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw201"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/647952"},{"key":"e_1_3_3_20_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","author":"CLSI","year":"2015","unstructured":"CLSI. 2015. M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"10"},{"key":"e_1_3_3_21_2","volume-title":"Performance standards for antimicrobial susceptibility testing: 27th informational supplement","author":"CLSI","year":"2017","unstructured":"CLSI. 2017. M100-S27. Performance standards for antimicrobial susceptibility testing: 27th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_22_2","unstructured":"EUCAST. 2017. Breakpoint tables for interpretation of MIC's and zone diameters. Version 7.1 March 2017. Available at http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_7.1_Breakpoint_Tables.pdf. Accessed March 2017."},{"key":"e_1_3_3_23_2","volume-title":"Performance standards for antimicrobial disk susceptibility tests","author":"CLSI","year":"2015","unstructured":"CLSI. 2015. M02-A12. Performance standards for antimicrobial disk susceptibility tests, 12th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"12"},{"key":"e_1_3_3_24_2","volume-title":"Development of in vitro susceptibility testing criteria and quality control parameters","author":"CLSI","year":"2016","unstructured":"CLSI. 2016. M23-A4. Development of in vitro susceptibility testing criteria and quality control parameters, 4th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"4"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00047-06"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00647-16"},{"key":"e_1_3_3_27_2","volume-title":"Pharmacokinetics and pharmacodynamics of delafloxacin in S. aureus murine thigh infection models","author":"Burak E","year":"2009","unstructured":"Burak E, Bortolon E, Molstad D, Wu Y, Jing H, Girard D. 2009. Pharmacokinetics and pharmacodynamics of delafloxacin in S. aureus murine thigh infection models, abstr A1-1941. 49th Intersci Conf Antimicrob Agents Chemother (ICAAC), 12 to 15 September 2009, San Francisco, CA."},{"key":"e_1_3_3_28_2","volume-title":"Pharmacokinetic-pharmacodynamic target attainment analyses supporting delafloxacin phase 3 dose regimen decisions","author":"Rubino CM","year":"2010","unstructured":"Rubino CM, Bhavnani SM, Burak E, Ambrose PG. 2010. Pharmacokinetic-pharmacodynamic target attainment analyses supporting delafloxacin phase 3 dose regimen decisions, abstr A1-681. 50th Intersci Conf Antimicrob Agents Chemother (ICAAC), 12 to 15 September 2010, Boston, MA."},{"key":"e_1_3_3_29_2","unstructured":"USCAST. 2017. Quinolone in vitro susceptibility test interpretive criteria evaluations V1.2 Available at http:\/\/www.uscast.org\/reports.html. Accessed May 2017."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01201-10"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh304"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3973-3975.2003"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00941-16"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00339-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00339-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:22:01Z","timestamp":1646475721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00339-18"}},"subtitle":[],"editor":[{"given":"Alexander J.","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1128\/JCM.00339-18"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00339-18","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"type":"print","value":"0095-1137"},{"type":"electronic","value":"1098-660X"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"2018-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00339-18"}}